Endeavor Biomedicines Inc.

Idiopathic Pulmonary Fibrosis

Clinical research in idiopathic pulmonary fibrosis with a focus on lung fibrosis and treatment response in patients living with progressive interstitial lung disease.

  • Idiopathic pulmonary fibrosis
  • Lung fibrosis
  • Interstitial lung disease

Research activity in this area centers on therapeutic options for chronic fibrotic disease affecting pulmonary function and respiratory health.

Respiratory Therapeutics

The sponsor’s research interest extends to respiratory medicine, particularly therapies aimed at modifying fibrotic processes within the lungs and supporting disease management in chronic pulmonary conditions.

  • Respiratory medicine
  • Pulmonary fibrosis
  • Fibrotic lung disease

These activities reflect a therapeutic emphasis on conditions where preserving lung structure and function is a central clinical concern.

Clinical Evaluation in Multinational Settings

Research is conducted across multiple collaborating sites in several countries, supporting multicenter clinical research in a complex pulmonary disease population.

  • Multicenter clinical research
  • International site collaboration
  • Pulmonary disease research

This geographic reach indicates sustained involvement in clinical investigation for patients with advanced respiratory disease across diverse healthcare settings.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    Investigated diseases:
    Austria Belgium France Germany Ireland Italy